Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
NCT00006046 · Ludwig Institute for Cancer Research, Other · Terminated
Key facts
| NCT number | NCT00006046 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer |
| Official title | Phase I Study of Humanized 3S193 (Anti-Lewis-Y) Antibody in Patients With Advanced Colorectal Carcinoma |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological |
| Interventions | monoclonal antibody hu3S193 |
| Enrollment | 7 |
| Start date | Jul 12, 2000 |
| Primary completion | Oct 5, 2001 |
| Completion | Sep 24, 2002 |
| First posted | May 21, 2003 |
| Last update posted | Oct 4, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: